Article Versions Notes

Tian C, Wei Y, Li J, Huang Z, Wang Q, Lin Y, Lv X, Chen Y, Fan Y, Sun P, et al. A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer. International Journal of Molecular Sciences. 2022; 23(5):2892. https://doi.org/10.3390/ijms23052892

Tian, Chenchen, Yufan Wei, Jianjun Li, Zhi Huang, Qiong Wang, Yingxue Lin, Xingping Lv, Yanan Chen, Yan Fan, Peiqing Sun, and et al. 2022. "A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer" International Journal of Molecular Sciences 23, no. 5: 2892. https://doi.org/10.3390/ijms23052892

Tian, C., Wei, Y., Li, J., Huang, Z., Wang, Q., Lin, Y., Lv, X., Chen, Y., Fan, Y., Sun, P., Xiang, R., Chang, A., & Yang, S. (2022). A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer. International Journal of Molecular Sciences, 23(5), 2892. https://doi.org/10.3390/ijms23052892